Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Atlanta’s leading healthcare centers are recruiting participants for studies focused on developing innovative treatments for conditions such as cancer, depression, high blood pressure, and kidney disease. Whether you’re searching for paid clinical research opportunities as a healthy volunteer or trials for specific conditions, Atlanta provides a wide range of research options to meet your needs.
Filter
2
Filter results
Results: 1,670
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Atlanta GA, Greenville SC, Nashville TN, New Orleans LA,
Sponsor: Coherus Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06657144
Phase 1, Recruiting
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
for
Low-Grade Serous Ovarian Cancer
Location: Atlanta GA, Basking Ridge NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 18+
Code: NCT06394804
Phase 2, Recruiting
A Smoke-Free Home Intervention in Tribal Communities
for
Tobacco-Related Carcinoma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06583148
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Atlanta GA, Durham NC, Cincinnati OH, Sarasota FL,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase 1, Recruiting
Tumor Treating Fields for the Treatment of Brainstem Gliomas
for
Glioma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT05310448
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
for
Resectable Lung Non-Small Cell Carcinoma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06008730
Phase 2, Recruiting
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Location: Atlanta GA, Chapel Hill NC, Columbus OH, Boston MA
Sponsor: Christine Ryan
Sex: All
Age: 18+
Code: NCT06043674
Phase 2, Recruiting
Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
for
Recurrent Classic Hodgkin Lymphoma,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 12+
Code: NCT05039073
Phase 2, Recruiting
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostatic Neoplasms, Castration-Resistant
Location: Atlanta GA, Knoxville TN, Myrtle Beach SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07225946
Phase 3, Recruiting
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Atlanta GA, Denver CO
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06768489
Phase 1, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Atlanta GA, Louisville KY, Orange City FL, Clermont FL,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase 1, Phase 2, Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Atlanta GA, Nashville TN, Chapel Hill NC, Columbus OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07441694
Phase 1, Recruiting
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma